Clinical Research Directory
Browse clinical research sites, groups, and studies.
Parenteral Antiplatelet Agents in Real-world Spanish PCI Patients
Sponsor: Fundación EPIC
Summary
This registry will provide exploratory and descriptive information regarding contemporary practice patterns of parenteral antiplatelet therapy in the PCI (Percutaneous Coronary Intervention) setting and will investigate as well the short-term effectiveness and safety of the currently available parenteral antiplatelet agents in a cohort of "real-world" patients undergoing PCI in Spain.
Official title: Practice Patterns of Antithrombotic Therapy in REAL-world Patients Undergoing PCI in Spain: Parenteral Antiplatelet Agents
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
717
Start Date
2022-03-14
Completion Date
2026-06-01
Last Updated
2026-02-10
Healthy Volunteers
No
Interventions
Parenteral antiplatelet agents
Patients undergoing PCI and receiving parenteral antiplatelet agents, cangrelor or glycoprotein IIb/IIIa inhibitors (GPIs), during the procedure as per clinical practice
Locations (12)
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain
Hospital Universitario de Cruces
Barakaldo, Spain
Hospital de Galdakao
Galdakao, Spain
Hospital Universitario de Cabueñes
Gijón, Spain
H.de Leon
León, Spain
Hospital Central de La Defensa Gómez Ulla
Madrid, Spain
Hospital Universitario de Navarra
Pamplona, Spain
Hospital Clinico Universitario de Salamanca
Salamanca, Spain
Hospital Universitario Marques de Valdecilla
Santander, Spain
Hospital Clinico Universitario Santiago de Compostela
Santiago de Compostela, Spain
Hospital Universitari Joan Xxiii
Tarragona, Spain
Hospital Universitario Lozano Blesa
Zaragoza, Spain